These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Wild type cardiac amyloidosis: is it time to order a nuclear technetium pyrophosphate SPECT imaging study? Shen CP; Vanichsarn CT; Pandey AC; Billick K; Rubenson DS; Mohan RC; Heywood JT; Srivastava AV Int J Cardiovasc Imaging; 2023 Jan; 39(1):201-208. PubMed ID: 36598681 [TBL] [Abstract][Full Text] [Related]
9. Estimating cancer risk from Einstein AJ; Shuryak I; Castaño A; Mintz A; Maurer MS; Bokhari S J Nucl Cardiol; 2020 Feb; 27(1):215-224. PubMed ID: 29850972 [TBL] [Abstract][Full Text] [Related]
10. Hydroxychloroquine cardiotoxicity in systemic lupus erythematosus: a report of 2 cases and review of the literature. Nord JE; Shah PK; Rinaldi RZ; Weisman MH Semin Arthritis Rheum; 2004 Apr; 33(5):336-51. PubMed ID: 15079764 [TBL] [Abstract][Full Text] [Related]
11. Hydroxychloroquine: a treatable cause of cardiomyopathy. Abbasi S; Tarter L; Farzaneh-Far R; Farzaneh-Far A J Am Coll Cardiol; 2012 Aug; 60(8):786. PubMed ID: 22898072 [No Abstract] [Full Text] [Related]
12. Case records of the Massachusetts General Hospital. Case 11-2011. A 47-year-old man with systemic lupus erythematosus and heart failure. Newton-Cheh C; Lin AE; Baggish AL; Wang H N Engl J Med; 2011 Apr; 364(15):1450-60. PubMed ID: 21488768 [No Abstract] [Full Text] [Related]
13. Non-invasive detection and differentiation of cardiac amyloidosis using Takasone K; Katoh N; Takahashi Y; Abe R; Ezawa N; Yoshinaga T; Yanagisawa S; Yazaki M; Oguchi K; Koyama J; Sekijima Y Amyloid; 2020 Dec; 27(4):266-274. PubMed ID: 32722948 [TBL] [Abstract][Full Text] [Related]
14. New clinical and ultrastructural findings in hydroxychloroquine-induced cardiomyopathy--a report of 2 cases. Soong TR; Barouch LA; Champion HC; Wigley FM; Halushka MK Hum Pathol; 2007 Dec; 38(12):1858-63. PubMed ID: 18061791 [TBL] [Abstract][Full Text] [Related]
15. (99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses. Bokhari S; Castaño A; Pozniakoff T; Deslisle S; Latif F; Maurer MS Circ Cardiovasc Imaging; 2013 Mar; 6(2):195-201. PubMed ID: 23400849 [TBL] [Abstract][Full Text] [Related]
16. Interpreting technetium-99m pyrophosphate cardiac scans to diagnose transthyretin cardiac amyloidosis: Need for due diligence. Butera B; Klingler D; Mccord JK; Ananthasubramaniam K J Nucl Cardiol; 2021 Aug; 28(4):1798-1801. PubMed ID: 32390109 [No Abstract] [Full Text] [Related]
18. A case of disappearing amyloid on technetium pyrophosphate scan. Wang A; Mahmood U; Tang X; Jain D; Pan S J Nucl Cardiol; 2023 Oct; 30(5):1986-1991. PubMed ID: 37340232 [TBL] [Abstract][Full Text] [Related]